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Candida spp. form a part of human and animal oral cavity flora. 
However Candida spp. is the main cause of dental related stomatitis in 
humans and stomatitis in dogs. Stomatitis treatment implies the use of 
azoles and polyenes to which yeasts build up resistance. The research 
is directed to the use of natural compounds such as essential oils. 
The aim of this paper is to define the antifungal activity of thyme 
oil on 15 clinical strains of Candida spp., isolated from humans and 
dogs and to determine if there is a difference in susceptibility between 
human and dog isolates. 
Sampling in patients with stomatitis was done by swabbing the 
denture or oral mucosa swab while sampling in dogs was done by 
swabbing the oral cavity mucosa after stomatitis has been diagnosed. 
In order to investigate the antifungal activity of thyme oil in vitro, 
microdilution method was used.
Thyme oil expressed antifungal effects on all investigated 
strains. Also, our data show that the values of minimum fungicide 
concentration (MFC) and minimum inhibitory concentration (MIC) are 
lower in human strains. Explanation is that in most cases, stomatitis 
in humans is asymptomatic and thus not treated, so Candida strains 
have not developed resistance. On the other hand, stomatitis in dogs 
is followed by a marked clinical picture and treated is by antimicotics 
(mostly by azoles), therefore resistant Candida strains are more likely 
to occur.  
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INTRoDUCTIoN
Yeasts of genus Candida are residential microorganisms which very often 
can be found in both human (Carvalhinho, 2012) and animal oral cavity. apart 
from the oral cavity, Candida is present in some other human and animal moist 
areas such as: skin, inner ear, conjunctival canal, mouth, digestive system and 
perianal area. Candida yeasts along with other microorganisms are microbes 
of healthy living beings, but in specific conditions they can cause opportunistic 
infections (Cleff et al., 2005). 
Candida albicans (C. albicans) is the main etiological factor of oral candidiasis 
in humans and other small animals. apart from C. albicans, other kinds of oral 
yeasts may be included in various pathogenic processes. In the available literature, 
the following are found: C. glabrata, C. krusei, C. tropicalis, C. dubliniensis, C. 
parapsilosis in humans or C. parapsilosis, and C. guilliermondi and C.tropicalis in 
dogs (moreti et al., 2006; Cleff et al., 2007; pozzatti, 2007; Yurayart et al., 2011).
There are different clinical manifestations of oropharyngeal candidiasis in 
humans, including pseudomembranous candidiasis (trush) and erythematous 
forms such as denture related stomatitis, which is often recurrent (Cannon et 
al., 1995). Wearing prosthetic appliances is commonly associated with denture 
stomatitis, which is characterized by inflamed mucosa covered by denture, more 
often under the upper denture (Wilson, 1998). patients with denture related 
stomatitis may complain of burning sensation, discomfort, or bad taste. However 
patients very often do not have any symptoms. There are many pre-dilutional   
factors  that  influence  denture  stomatitis,  including  age  of  denture,  denture 
cleanliness, continuous constant denture wearing, denture trauma which appears 
as a consequence of wearing dentures, smoking, dietary factors,  pH of denture 
plaque (Soysa et al., 2004, 2006). Denture stomatitis is a disease of fungal and 
bacterial origin, and  C. albicans is most frequently isolated yeast from the patients’ 
oral cavities (baena-monroy et al., 2005). Denture is more often a reservoir of 
microorganisms from which they can spread and cause diseses to other organs.
Stomatitis in dogs is characterized by erythematous oral mucous membrane 
which is ulcerous and covered with pseudo membranes, with halitosis and 
hypersalvation (mcKcever and Klausener, 1986).
opportunistic infections in dogs develop as a consequence of deteriorating 
defense mechanisms, immunosuppression and prolonged antibiotic treatment 
(moreti et al., 2006; Cleff et al., 2007; ong et al., 2010; Yurayart et al., 2011). 
Different Candida species are very important pathogenic factors in small animals 
and they are linked to urinary infections, (ozawa et al., 2005) skin lesions 
(moretti et al., 2004), otitis and systematic infections (brown et al., 2005). 
Today candidiosis is a problem of public health due to resistance to 
conventional antifungal medicines and there are some reports on relapsing 
disease especially in immunocompromised patients (Sanglard and Kvota, 2002;   
Kolombo and guimaraes, 2003; pozzatti et al., 2010).
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In general, oral C. albicans isolates have high levels of susceptibilities to 
a range of antifungal agents (Kuriyama et al., 2005), but some studies have 
shown high levels of azoles resistance in C. albicans strains isolated from 
the throat and mouth (paniaqua et al., 2002; manifredi et al., 2006). owing to 
their antibacterial effects, essential oils are the alternative for antibiotics in the 
pharmaceutical industry (bakkali, 2008). The increase of C. albicans resistance 
to antifungal medicines encourages the research of new therapeutic alternatives 
such as essential oils (giordani et al., 2004; Cavaleiro et al., 2006).
Studies on essential oils have a goal to examine active compounds with 
a wide spectrum of effects, low toxicity and low prices (Rochette et al., 2003). 
Treatment of fungal infection in veterinary medicine is limited to conventional 
polyenes and triazoles. additionally, these medicines have adverse effects and 
relatively high prices, especially when they are used for animals (Sanglard, 
2002; mondelo et al., 2003; pressler et al., 2003; Rochette et al., 2003; lukman 
et al., 2007).
The aim of this study is to:
1. determine antifungal activity (minimum inhibitory concentration – mIC and 
minimum fungicide concentration – mfC) 
2. determine if there is a difference in susceptibility profile of Candida spp. 
isolated in both humans and dogs
maTeRIal aND meTHoDS
Essential oils
In the research, the essential thyme oil used (Citychem, belgrade, Serbia), 
was obtained by water vapour distillation under of Thymus vulgaris flowers. The 
percentage of particular components of thyme oil is given in Table 1.
Fungal strains
The study has included the research of 15 clinical isolates of Candida spp. 
isolated in seven patients with diagnosed dental related stomatitis (5 C.albicans, 
Substance %
Thymol 46.0
ρ-cymene 27.5
γ-terpinene 9.0
linalool 6.5
Carvarcrol 2.5
β-myrcene 2.4
Terpinen-4-ol 1.5
Table 1. Components of thyme oil
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2  C.glabrata, 2 C.krusei and 1 C.  tropicalis)  and  five  dogs  with  stomatitis  (3 
C.albicans, 1 C.parapsilosis and 1 C. krusei).
The sampling in patients was done by swabs taken from their dentures (in 
patients with dental stomatitis) or by oral mucosa swabs. The sampling in dogs 
was done by mucosa swabs of the oral cavity when stomatitis has been diagnosed. 
Swabs were transported to the microbiological laboratory in a period no 
longer than 30 minutes from the moment of sampling. material was seeded on 
CHRomagar  Candida plates (CHROMagar,  Paris,  France)  and incubated at 
37oC for 48 hours. The identification of Candida strains was done according to the 
specific appearance of the colonies as defined by the manufacturer.
In vitro antifungal activities of thymes oil
Susceptibility of strains to thyme oil has been investigated by the microdilution 
method according to the standardized protocol by The european Committee on 
antimicrobial Susceptibility Testing – eUCaST (eUCaST). Serial oil dilutions were 
prepared in RPMI 1640 with 2% of glucose, in the concentration range 0.1 = 
16 µl ml-1.
before testing, 15 Candida isolates,  together with two reference strains (C. 
albicans aTCC 24433 and C. krusei aTCC 6258) were cultivated on Sabouraud 
dextrose agar plates (oxoid, basingstoke, United Kingdom) at 37oC during 24 
hours. Yeast suspension has been prepared in sterile 0.9% NaCl and adjusted 
to 0.5 McFarland  standard  of  turbidity  (which  fits  the  size  of  inoculums  of 
1-5×106CfU/ml).
each chamber of the microtitration plates was inoculated by adding 100 µl 
of yeast suspension and 100 µl of corresponding concentration of thyme oil. 
The test has also included three controls: positive control/growth control (fungi 
in pRmI 1640 without thyme oil), negative control (fungi in solution 2 µg/ml of 
amphotericine b) and sterility control (only RpmI 1640 without yeast suspensions). 
microtitration plates were incubated at 37ºC. The results have been read 
visually after 24 and 48 hours on the basis of chamber’s content turbidity. mIC 
is  defined  as  the  lowest  concentration  of  solution  which  causes  a  significant 
decrease in turbidity comparing to the positive control.  
Determination of minimum fungicide concentration (mfC) is done by seeding 
20 µl from all clear wells on SDa incubated at 37ºC for 24-48 hours.
ReSUlTS
essential thyme oil has manifested antifungal effects to all tested strains. The 
susceptibility results presented as mIC and mfC values are shown in Table 2 for 
Candida strains isolated from humans and Table 3 for strains isolated from dogs. 
Strains of the species C.albicans have shown the greatest susceptibility to 
thyme oil, while between other Candida species difference in mIC/mfC values 
has not been noticed. 
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Strain number Species mIC (µl ml-1) mfC (µl ml-1)
36a C.albicans  0.5 1
62a C.albicans  0.2 0.5
80a C.albicans  0.2 0.5
82a C.albicans  0.2 0.5
87a C.albicans  0.2 0.5
90T C.tropicalis  0.5 1
49g C.glabrata  0.5 1
60g C.glabarata  0.5 1
33K C. krusei  0.5 1
43K C.krusei  0.5 1
Table 2. The results of Candida spp. susceptibility isolated from humans
Strain number Species mIC (µl ml-1) mfC (µl ml-1)
a12 C.albicans 5.0 5.0
a2 C.albicans 2.5 5.0
a8 C.albicans 2.5 5.0
K4 C.krusei 5.0 10
p15 C.parapsilosis 1.25 5.0
Table 3. Susceptibility results of Candida spp. isolated from dogs
figure 1. Comparison of gm values for human and dog isolates
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on the basis of our results it may be concluded that Candida spp. isolated 
from humans shows higher susceptibility to thyme oil compared to Candida spp. 
isolated from dogs. Comparison of geometric mean (gm) values for human and 
dog isolates is given in figure 1.
DISCUSSIoN
The effect of essential oils and their main components on Candida spp.  have 
been confirmed in in vitro and in vivo studies ( giordani et al., 2004; Tamperi et 
al., 2005; Duarte et al., 2005; pinto et al., 2006; He et al., 2007; palmeira- de 
oliveira et al., 2009). Their activity can usually be presumed on the basis of their 
chemical content. essential oils have antifungal activity since they contain high 
content of phenol. Thymus spp. is very rich in phenol (thymol). Thymus zygis 
is classified as a fungicide due to its powerful effect on C.albicans ( pina - vaz, 
2004). various studies have shown that thyme oils manifest the highest antifungal 
activity compared to other essential oils (omran, 2009).
Scanning by Sem, braga and del Sasso (2008) have shown that the effect 
of thymol causes the change of susceptibility of the cell membrane, degradation 
of cellular wall, leaking of cell content, coagulation and cell lysis (bakkali et al., 
2008; palmeira de olivera et al., 2009). Concentrations below the mIC values 
significantly inhibited germ tube formation, an important virulence factor (Pina - 
vaz, 2004). 
Hammer (1999) has also defined MIC of thyme oil for C.albicans from 0.03% 
(0.3 µl ml-1) by using the microdilution method.  In this study the value was 0.02% 
(0.2 µl ml-1) for human isolates of C.albicans. 
In the study of omran et al. (2010) where antifungal activity of thyme oil was 
investigated by disc diffusion method, mIC for Candida spp. was 2 mg/mL=0.02%. 
C.albicans showed the highest susceptibility, followed by C.krusei and C.glabata 
(omran et al., 2009). In our research, C.albicans strains also expressed the highest 
susceptibility. C. krusei is less susceptible to thyme oil and to other essential oils 
due to its cellular structure, as well as the intensified action of cell pumps which 
disturb the entrance of essential oils into the cell (mondelo et al., 2003; pozzatti, 
2007). 
our study also demonstrated higher susceptibility of human Candida 
spp. comparing to the strains Candida spp. isolated from dogs, which could be 
explained in a way that dental related stomatitis in patients very often is not treated. 
Therefore, human strains of Candida spp. have not developed resistance. on 
the other hand, in dogs, stomatitis has been accompanied by a stronger clinical 
picture, and is treated by antimicotics (mostly azoles) therefore resistant profiles 
of Candida spp. are more likely to occur. 
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osetlJivost  soJeva CANDIDA SPP. IZOLOVANIH KOD ČOVEKA I PSA SA 
stomatitisom na etarsKo ulJe timiJana
ŽIVKOVIĆ R, PERIĆ MIRJANA, ARSIĆ-ARSENIJEVIĆ VALENTINA , MARTINOVIĆ Ž, 
PEKMEZOVIĆ MARINA, STOJIĆ Ž, RAIČKOVIĆ VANJA i ĐURIŠIĆ S
SADRŽAJ
Candida spp. je sastavni deo mikrobioma usne duplje čoveka i psa. Među-
tim Candida spp. predstavlja glavni uzročnik proteznog stomatitisa kod čoveka i 
stomatitisa kod psa. Terapija stomatitisa podrazumeva korišćenje azola i poliena 
na koje poslednjih godina gljivice razvijaju otpornost. Istrživanja se usmeravaju 
ka primeni prirodnih preparata kao što su etarska ulja. Cilj rada je utvrdi anti-
fungalnu aktivnost ulja timijana na kliničke izolate Candida spp. čoveka i psa, i 
utvrdi da li postoji razlika u osetljivosti sojeva Candide spp. izolovanih kod čoveka 
i psa. Uzorkovanje kod pacijenata sa stomatitisom je vršeno brisom proteze ili 
brisom sluzokože. Kod pasa je uzrokovanje vršeno brisom sluzokože usne duplje 
kada je dijagnostikovan stomatitis. Zasejani sojevi su in vitro tretirani korišćen-
jem mikrodilucione metode da bi se utvrdilo da li ulje timijana deluje na kliničke 
izolate Candida spp. čoveka i psa. Rezultati pokazuju da su vrednosti minimalne 
fungicidne koncentracije (mfC) i minimalne inhibitorne koncentracije (mIC) man-
je kod čoveka. Stomatitis je kod ljudi najčešće je asimptomatski, pacijenti se ne 
podvrgavaju lečenju, pa sojevi Candida spp. nisu razvili rezistenciju na antifungi-
cidne preparate. Kod pasa stomatitis je praćen burnijom kliničkom slikom, leči se 
antimikoticima (uglavnom azolima) pa je verovatnoća pojave rezistentnih sojeva 
Candida spp. veća.
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